Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
2026
Alzheimers Res Ther. 2026 Mar 21;18(1):77. doi: 10.1186/s13195-026-02019-2.PMID: 41865008
2026
Alzheimers Res Ther. 2026 Mar 21;18(1):77. doi: 10.1186/s13195-026-02019-2.PMID: 41865008